Table 8.
Relative risk regressions for Long-COVID.
| Variable | Bivariate regressions | Adjusted for age and sex | ||
|---|---|---|---|---|
| RR | CI | RR | CI | |
| n | 55 | 55 | ||
| Age | 0.99 | 0.98–1.01 | ||
| Male | 1.11 | 0.80–1.56 | ||
| BMI: 35–40 kg/m2 | 1.32 | 1.00–1.76 | 1.37* | 1.04–1.79 |
| BMI: > 40 kg/m2 | 1.56** | 1.25–1.95 | 1.61** | 1.26–2.06 |
| CCI | 1.01 | 0.95–1.08 | 1.03 | 0.96–1.11 |
| Septic shock at ICU admission | 1.14 | 0.71–1.83 | 1.14 | 0.72–1.82 |
| SOFA-Score at ICU admission | 0.98 | 0.93–1.04 | 0.98 | 0.93–1.04 |
| ECMO | 1.17 | 0.84–1.62 | 1.14 | 0.79–1.64 |
| CRRT | 1.09 | 0.73–1.63 | 1.08 | 0.70–1.66 |
| Logarithm of lowest Horovitz-index at ICU | 1.04 | 0.75–1.44 | 1.06 | 0.74–1.53 |
| Logarithm of duration of mechanical ventilation at ICU | 1.11 | 0.90–1.37 | 1.09 | 0.87–1.36 |
| VTE during ICU stay | 1.11 | 0.83–1.48 | 1.13 | 0.84–1.54 |
| Direct transfer to our ICU from other hospital | 1.03 | 0.77–1.38 | 1.06 | 0.80–1.40 |
| DVT | 0.99 | 0.72–1.36 | 1.00 | 0.72–1.38 |
Relative risks with 95%-confidence intervals for Long-COVID from robust Poisson regressions (significance levels: * = 5%, ** = 1%).
BMI Body-Mass-Index, CCI Charlson ComorbidityIndex, CI Confidence interval, CRRT Continuous renal replacement therapy, DVT Deep vein thrombosis, ECMO extracorporeal membrane oxygenation, ICU Intensive care unit, RR Relative risk, VTE Thromboembolic complications.